| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c24684033fba97d1ad845ce453a57e3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
1991-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d851b663a29675d5c2fcdb42882ef59c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a672076515b285ef08852f545f6ccbba |
| publicationDate |
1993-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9300088-A1 |
| titleOfInvention |
Use of phenylpyrazoline derivatives for the treatment of elevated intraocular pressure |
| abstract |
The invention concerns compounds of the formula (I), in which R<1> may be for instance hydrogen or (C1-C5)-alkyl and R<2> for instance (C1-C5)-alkyl. When applied directly to the eye, such compounds produce a reduction in the intraocular pressure. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837723-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1297849-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0633025-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7638516-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1297849-A1 |
| priorityDate |
1991-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |